Weak Link in the Cancer Treatment Chain: Low-Quality Biopsies
Histopathology (commonly known as ‘biopsy’) is the gold standard in cancer diagnosis and now frequently used to identify the best treatment regime using genetic analysis. It seems that 1 in 5 samples are of poor quality and cannot be used for genetic analysis. This was particularly true for samples coming from centres far away from specialised centres […]
Comments Off on Weak Link in the Cancer Treatment Chain: Low-Quality Biopsies